Ajanta Pharma Buyback Record Date is finalized.Â
Ajanta Pharma is a specialty pharmaceutical formulation company engaged in developing, manufacturing, and marketing finished dosages. The company has a well-diversified business model regarding markets, therapies, and products.
The company has de-risked the business to a large extent from possible uncertainties in the business environment in different geographies. The largest contribution of about 73% of business comes from a wide range of branded generic products in around 30 Asian countries (including India) and Africa.
Each geography has been carefully chosen for therapies and products. Additionally, about 21% comes from the generics business in the world’s largest market the USA, and the remaining 6% comes from anti-malaria institutional business in Africa.
Ajanta Pharma operates 7 state-of-the-art manufacturing facilities in India. Out of this, 6 facilities manufacture finished formulations and 1 manufactures Active Pharmaceutical Ingredients (APIs), primarily for captive consumption.
Ajanta Pharma Buyback Record Date, Other Details
| Ajanta Pharma Buyback Dates | 5 – 11 June 2024 |
| Ajanta Pharma Buyback Price | INR 2,770 per share |
| Market Price on Buyback Approval | INR 2,233.10 per share |
| Buyback Premium on Market Price | 18.73% |
| Buyback Offer Size (Shares) | 1,028,881 shares |
| Buyback Offer Size (Amount) | INR 285 crore |
| Offer Type | Tender Offer |
| Promoter Participation | Yes |
| Face Value | INR 2 per share |
| Listing At | BSE, NSE |
Ajanta Pharma Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 26 April 2024 |
| Buyback Approval Date | 2 May 2024 |
| Public Announcement of Buyback | 6 May 2024 |
| Ajanta Pharma Buyback Record Date | 30 May 2024 |
| Buyback Opening Date | 5 June 2024 |
| Buyback Closing Date | 11 June 2024 |
| Cut-off Date to receive completed tender forms by Registrar | 11 June 2024 |
| Verification Date by the Registrar | 17 June 2024 |
| Return of unaccepted shares by Registrar | 19 June 2024 |
| Extinguishment of accepted shares | 28 June 2024 |
Ajanta Pharma Buyback 2024 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Ajanta Pharma Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | 1/8 | 12.5 |
| General category (for all other Eligible Shareholders) | 1/128 | 0.78 |
A small shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.
Ajanta Pharma Financial Performance
| FY 2022 | FY 2023 | FY 2024 | |
| Revenue | 3,340.99 | 3,742.64 | 4,208.71 |
| Total Expenses | 2,411.69 | 2,959.39 | 3,036.77 |
| Net income | 712.68 | 587.98 | 816.17 |
Calculation of Investment in Buyback
| Maximum market value of a shareholder as on record date | INR 2,00,000 |
| Buyback price per share | INR 2,770 |
| Maximum shares for small shareholders (2,00,000/2,770) | 73 shares * |
| The closing price of the stock as of 2 May 2024 | INR 2,233.10** |
| Maximum amount invested in buyback (INR 2,233.10 x 73 shares) | INR 1,63,016 |
** For simplicity, we have considered the price on the buyback approval date
Ajanta Pharma Buyback Acceptance Ratio
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 73 | 10 | 10 (100%) | 5,369.0 | 3.29 |
| 73 | 10 | 20 (200%) | 10,738.0 | 6.59 |
| 73 | 10 | 30 (300%) | 16,107.0 | 9.88 |
Registrar of Ajanta Pharma Buyback 2024
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone:Â +91 810 811 4949
Email:Â [email protected]
Website:Â www.linkintime.co.in
Manager of Ajanta Pharma Buyback 2024
VIVRO FINANCIAL SERVICES PRIVATE LIMITED
607/608 Marathon Icon, Opp. Peninsula
Corporate Park Off. Ganpatrao Kadam Marg,
Veer Santaji Lane, Lower Parel,
Mumbai-400 013, Maharashtra, India
Phone:Â +91 22 6666 8040/41/42
Email:Â [email protected]
Website: www.vivro.net
Process to Participate in Ajanta Pharma Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Ajanta Pharma buyback dates?
Ajanta Pharma’s share buyback opens on 5 June 2024 and closes on 11 June 2024.
Which type of buyback is Ajanta Pharma buyback offer?
Ajanta Pharma’s buyback is a tender offer.
What is Ajanta Pharma buyback price?
Ajanta Pharma buyback price is INR 2,770 per share.
What is Ajanta Pharma buyback record date?
Ajanta Pharma buyback record date is 30 May 2024.
How to participate in Ajanta Pharma share buyback?
Ajanta Pharma’s share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.
